QCG
ZEAL

Quadrant Capital Group’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Quadrant Capital Group’s Portfolio ZEAL Stock Details ZEAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-32
Closed -$1K – 2634
2021
Q1 		$1K Buy
+32
New +$1.08K ﹤0.01% 2346

Other funds holding ZEAL

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Quadrant Capital Group's ZEAL Position: Q2 2021 in Review

Quadrant Capital Group sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q2 2021, closing a stake of 32 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in ZEAL in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 16 funds tracked by Wall St. Rank hold ZEAL as of Q2 2021.

  • Quadrant Capital Group reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Quadrant Capital Group sold 32 Zealand Pharma A/S American Depositary Shares shares in Q2 2021, an estimated $1K.
  • Quadrant Capital Group first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Quadrant Capital Group's Zealand Pharma A/S American Depositary Shares position peaked at $1K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q2 2021.

Based on Quadrant Capital Group's 13F filing for Q2 2021, filed 9 Aug 2021.